시장보고서

상품코드

1565716

전신 마취제 시장 : 유형별, 투여 경로별, 수술 유형별, 최종사용자별, 국가별, 지역별 - 산업 분석, 시장 규모, 시장 점유율, 예측(2024-2032년)

General Anesthesia Drugs Market, By Type, By Route Of Administration, By Surgery Type, By End-user, By Country, and By Region - Industry Analysis, Market Size, Market Share & Forecast from 2024-2032

발행일: 2024년 10월 | 리서치사:

AnalystView Market Insights | 페이지 정보: 영문 260 Pages | 배송안내 : 2-3일 (영업일 기준)

샘플 요청 목록에 추가

※ 본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문 목차를 참고해주시기 바랍니다.

보고서 하이라이트

세계 전신 마취제 시장 규모는 2023년 51억 1,420만 달러로 평가되며 2024-2032년 연평균 4.00%의 CAGR로 성장할 것으로 예상됩니다.

전신 마취제 시장 - 시장 역학

최소침습수술(MIS)로 치료되는 만성 질환의 빈도 증가

만성질환의 유병률 증가가 MIS 전신 마취제의 성장을 주도하고 있습니다. 만성질환에 대한 외과적 치료의 수요 증가는 수술을 원하는 환자 수 증가와 직결되어 안전하고 효과적인 마취제에 대한 수요 증가를 촉진하고 있습니다. 회복 시간을 단축하고 입원 기간을 단축할 수 있는 MIS 기술의 채택이 증가하고 있는 것도 의료 서비스 제공자의 마취제 사용 증가에 중요한 원동력이 되고 있습니다. 이러한 추세는 수술 중 환자의 편안함과 안전성을 높여주는 첨단 전신 마취제의 개발과 채택을 촉진하고, 궁극적으로 효율적인 수술 솔루션에 대한 수요 증가에 따른 시장 확대에 기여하고 있습니다. 예를 들어, Minimal Invasive Surgery Journal(MIS 저널)에 게재된 논문에 따르면, 최소침습수술(MIS) 관련 논문 58편이 접수되어 37편의 총설, 10편의 원저, 1편의 체계적 문헌인사이트이 게재됐습니다. 이 체계적 문헌인사이트는 경피적 대동맥판막 이식술에서 컴퓨터 보조를 통한 교차연동 수술의 품질 평가를 다루고 있으며, 이는 간세포암에서 관상동맥 재접근 및 경피적 대동맥판막 이식술(TAVI)의 재시술을 용이하게 할 수 있는 새로운 개척자 역할을 할 수 있습니다. 새로운 개척자가 될 수 있습니다.

전신 마취제 시장 - 주요 인사이트

당사의 연구 분석가들은 세계 시장이 2024-2032년 연평균 4.00%의 CAGR로 성장할 것으로 예측하고 있습니다.

2023년 유형별로는 프로포폴 부문이 가장 높은 시장 점유율을 기록했습니다.

투여 경로별로는 정맥주사(IV) 부문이 2023년 시장을 장악했습니다.

수술 유형별로는 무릎 및 고관절 치환술 부문이 예측 기간 동안 시장을 주도할 것으로 보입니다.

지역별로는 2023년 북미가 가장 높은 매출을 기록했습니다.

전신 마취제 시장 - 세분화 분석:

세계 전신 마취제 시장은 유형, 투여 경로, 수술 유형, 최종사용자 및 지역의 5 가지 범주로 분류됩니다.

시장은 유형별로 프로포폴, 데스플루란, 세보플루란, 기타 등 4개 부문으로 분류되며, 2023년에는 프로포폴 카테고리가 시장을 장악하고 예측 기간 동안 가장 빠른 CAGR로 성장할 것으로 예상됩니다. 프로포폴은 빠른 마취 시작과 회복 시간으로 환자의 편안함과 수술 효율을 향상시키는 것으로 알려져 있습니다. 마취 도입 및 유지에 자주 사용되며 다양한 수술 및 진단 수술에 적응할 수 있는 선택입니다. 또한, 짧은 반감기와 빠른 대사 등 우수한 약동학적 프로파일도 마취과 의사들에게 매력적인 요소로 작용합니다.

시장은 투여 경로에 따라 흡입과 정맥 내 두 가지로 나뉩니다. 가장 높은 매출 점유율을 차지하는 것은 정맥 투여(IV) 분야입니다. 이러한 성장 추세는 주로 정맥 마취제 투여의 발전, 효과, 편의성 등 여러 가지 중요한 변수에 의해 주도되고 있습니다. 정맥 마취가 선호되는 이유는 빠른 효과 발현과 약물 투여를 정확하게 제어할 수 있기 때문에 복잡한 수술에 대응하고 환자의 안전을 보장하는 데 필수적입니다. 실시간으로 용량을 변경할 수 있기 때문에 마취과 의사는 환자의 요구 사항과 수술 요구 사항에 따라 마취 깊이를 조정할 수 있습니다.

전신 마취제 시장 - 지리적 인사이트

지리적으로는 북미, 아시아태평양, 중동 및 아프리카, 라틴아메리카, 유럽이 포함됩니다. 이 구역은 어떤 국가가 비즈니스를 가져오는지에 따라 더 세분화됩니다.

북미 전신 마취제 시장은 높은 만성질환 유병률, 기술 발전, 중요한 의료 인프라 등 여러 주요 변수에 힘입어 2023년 지배적인 시장으로 부상할 것으로 예상되며, CVD, 암 등 수술이 필요한 만성질환의 빈도가 증가함에 따라 전신마취에 대한 수요가 증가할 것으로 예상됩니다.

아시아태평양의 전신 마취제 시장은 의료비 상승, 인구 증가로 인한 수술 수요 증가, 기술 발전으로 인해 빠르게 성장하고 있습니다. 아시아태평양의 인구가 많고 다양하며, 만성 질환의 빈도가 증가하고, 수술의 필요성이 증가함에 따라 전신마취의 필요성이 증가하고 있습니다. 중국과 인도 정부는 의료 및 인프라, 의료 기술에 많은 투자를 하고 있으며, 이는 시장 성장의 원동력이 되고 있습니다.

전신 마취제 시장 - 경쟁 상황:

전신 마취제 시장은 화이자, 파이온 AG, B.Braun Melsungen, Avet Pharmaceuticals Inc. 등 전통 있는 제약회사들이 풍부한 제품 라인업과 원활한 유통 채널로 시장을 독점하고 있습니다. 이들 기업은 연구개발에 대한 투자도 늘리고 있습니다. 또한, 중소기업과 제네릭 제약사들이 시장 점유율을 높이기 위해 저가형 제품의 존재감도 커지고 있습니다. 안전하고 효과적인 마취제에 대한 수요가 증가함에 따라 각 회사는 제품 라인업을 강화하고 시장을 확대하기 위해 전략적 제휴, 합병 및 인수를 활발히 진행하고 있습니다.

소개
북미
- 개요
- 북미의 주요 제조업체
- 미국
- 캐나다
유럽
- 개요
- 유럽의 주요 제조업체
- 독일
- 이탈리아
- 영국
- 프랑스
- 러시아
- 네덜란드
- 스웨덴
- 폴란드
- 기타
아시아태평양(APAC)
- 개요
- 아시아태평양의 주요 제조업체
- 인도
- 중국
- 일본
- 한국
- 호주
- 태국
- 인도네시아
- 필리핀
- 기타
라틴아메리카
- 개요
- 라틴아메리카의 주요 제조업체
- 브라질
- 멕시코
- 아르헨티나
- 콜롬비아
- 기타
중동 및 아프리카
- 개요
- 중동 및 아프리카의 주요 제조업체
- 사우디아라비아
- 아랍에미리트
- 이스라엘
- 터키
- 알제리
- 이집트
- 기타

제12장 주요 벤더 분석 - 전신 마취제 업계

경쟁 대시보드
기업 개요
- Pfizer Inc.
- Paion AG
- B. Braun Melsungen
- Avet Pharmaceuticals Inc
- Baxter International Inc.
- Abbott Laboratories
- Fresenius SE and Co. KGaA
- Abbvie Inc,
- AstraZeneca plc
- Hikma Pharmaceuticals plc
- 기타

제13장 애널리스트의 전방위 전망

ksm 24.10.28

REPORT HIGHLIGHT

General Anesthesia Drugs market size was evaluated at USD 5,114.2 million in 2023, rising at a CAGR of 4.00% from 2024 to 2032.

General anesthetic drugs are essential for establishing and maintaining a state of unconsciousness without pain during a variety of surgical operations. These medications, which are delivered intravenously or via inhalation, are utilized in a variety of surgeries, including cardiac, orthopedic, oncology, and gastrointestinal procedures.

General Anesthesia Drugs Market- Market Dynamics

Increasing Frequency of Chronic Illnesses Treated with Minimally Invasive Surgery (MIS)

Higher prevalence rates of chronic diseases are driving the growth of MIS general anesthesia drugs. A greater demand for surgical treatment in chronic diseases translates directly into a higher number of patients seeking surgery, thus fueling increased demand for safe and effective anesthesia drugs. Increased adoption of MIS techniques, which often result in quicker recovery times and shorter hospital stays, are an important driver of increased use by healthcare providers. This trend encourages the development and adoption of advanced general anesthesia drugs that enhance patient comfort and safety during procedures, ultimately contributing to the expansion of the market in response to the growing demand for efficient surgical solutions. For instance, an article published in the Minimal Invasive Surgery Journal (MIS journal) stated that 58 papers on minimal invasive surgery (MIS) were accepted and published, including 37 reviews, 10 original articles, and one systematic review. The systematic study addressed computer-assisted quality evaluation for surgeries commissural alignment in transcatheter aortic valve implantation, which may be a new frontier to ease coronary re-access and redo transcatheter aortic valve implantation (TAVI) in hepatocellular carcinoma.

General Anesthesia Drugs Market- Key Insights

Our research analyst estimates that the global market will develop at a CAGR of 4.00% from 2024 to 2032.

In 2023, the propofol sector had the highest market share based on Type segmentation.

Based on Route Of Administration segmentation, The intravenous (IV) Route Of Administration segment dominated the market in 2023.

The knee and hip replacement sector is expected to lead the market over the projection period, according to Surgery Type segmentation.

On the basis of region, in 2023, North America generated the highest revenue.

General Anesthesia Drugs Market- Segmentation Analysis:

The global vehicle-mounted spotlights market is divided into five categories: Type, Route Of Administration, Surgery Type, End-user, and region.

The market is classified into four segments based on the type: Propofol, Desflurane, Sevoflurane, and Others. In 2023, the propofol category dominated the market and is predicted to grow at the quickest CAGR over the forecast period. Propofol is known for its rapid onset and recovery times, which improve patient comfort and procedural efficiency. It is frequently used for anesthesia induction and maintenance, giving it an adaptable option for a wide range of surgical and diagnostic operations. The agent's good pharmacokinetic profile, which includes a short half-life and quick metabolism, adds to its appeal among anesthesiologists.

The market is separated into two types based on the route of administration: inhalation and intravenous. The intravenous (IV) sector had the highest revenue share. This growing trend is primarily driven by a number of significant variables, including advances in IV anesthetic delivery, efficacy, and convenience. IV anesthesia is favored because of its quick onset of effect and precise control over drug administration, which are critical for handling complex surgical operations and guaranteeing patient safety. The ability to modify dosage in real time enables anesthesiologists to tailor anesthetic depth based on the patient's demands and the surgical requirements.

General Anesthesia Drugs Market- Geographical Insights

Geographically, this market encompasses North America, Asia Pacific, the Middle East, and Africa, Latin America, Europe. These zones are further split based on which countries bring business.

The North American general anesthesia medicines market dominated in 2023, driven by a number of crucial variables, such as the high prevalence of chronic diseases, technological improvements, and significant healthcare infrastructure. The increased frequency of chronic illnesses such as CVD and cancer, which frequently necessitate surgical procedures, increases the demand for general anesthesia.

The Asia Pacific general anesthetic medicines market is quickly expanding as a result of rising healthcare costs, a growing population with increased surgical needs, and technological improvements. The large and diverse population of APAC, as well as the rising frequency of chronic illnesses and the requirement for surgical operations, all contribute to increased need for general anesthesia. Governments in China and India are investing heavily in healthcare infrastructure and medical technology, which is driving market growth.

General Anesthesia Drugs Market- Competitive Landscape:

The general anesthesia drugs market is characterized by a few main players, including established pharmaceutical companies such as Pfizer Inc., Paion AG, B. Braun Melsungen, and Avet Pharmaceuticals Inc., which dominate the market with a massive product line and smooth distribution channels. These players have also increased their investments in R&D. Low-cost versions are also gaining prominence in the quest for market share by smaller firms and generic manufacturers. Strategic alliances, mergers, and acquisitions mushroom as companies strive to build strength in their product offerings and increase their reach into the marketplace at a time when demand for safe, effective anesthesia is ever-increasing.

Recent Developments:

In April 2024, Baxter increased their pharmaceutical offering in the United States with the introduction of Ropivacaine Hydrochloride Injection, USP. This new medicine is packaged in a convenient, ready-to-use, single-dose infusion bag.

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

GLOBAL GENERAL ANESTHESIA DRUGS MARKET KEY PLAYERS- DETAILED COMPETITIVE INSIGHTS

Pfizer Inc.
Paion AG
B. Braun Melsungen
Avet Pharmaceuticals Inc
Baxter International Inc.
Abbott Laboratories
Fresenius SE and Co. KGaA
Abbvie Inc,
AstraZeneca plc
Hikma Pharmaceuticals plc
Others

GLOBAL GENERAL ANESTHESIA DRUGS MARKET, BY TYPE- MARKET ANALYSIS, 2019 - 2032

Propofol
Desflurane
Sevoflurane
Others

GLOBAL GENERAL ANESTHESIA DRUGS MARKET, BY ROUTE OF ADMINISTRATION- MARKET ANALYSIS, 2019 - 2032

Inhalation
Intravenous

GLOBAL GENERAL ANESTHESIA DRUGS MARKET, BY SURGERY TYPE- MARKET ANALYSIS, 2019 - 2032

Knee and hip replacements
Cancer surgery
Heart surgeries
General surgery

GLOBAL GENERAL ANESTHESIA DRUGS MARKET, BY END-USER- MARKET ANALYSIS, 2019 - 2032

Ambulatory surgical centers
Hospital

GLOBAL GENERAL ANESTHESIA DRUGS MARKET, BY REGION- MARKET ANALYSIS, 2019 - 2032

North America
The U.S.
Canada
Europe
Germany
France
Italy
Spain
United Kingdom
Russia
Netherlands
Sweden
Poland
Rest of Europe
Asia Pacific
India
China
South Korea
Japan
Australia
Thailand
Indonesia
Philippines
Rest of APAC
Latin America
Brazil
Mexico
Argentina
Colombia
Rest of LATAM
The Middle East and Africa
Saudi Arabia
United Arab Emirates
Israel
Turkey
Algeria
Egypt
Rest of MEA

1. General Anesthesia Drugs Market Overview

1.1. Study Scope
1.2. Market Estimation Years

2. Executive Summary

2.1. Market Snippet
- 2.1.1. General Anesthesia Drugs Market Snippet by Type
- 2.1.2. General Anesthesia Drugs Market Snippet by Route Of Administration
- 2.1.3. General Anesthesia Drugs Market Snippet by Surgery Type
- 2.1.4. General Anesthesia Drugs Market Snippet by End-user
- 2.1.5. General Anesthesia Drugs Market Snippet by Country
- 2.1.6. General Anesthesia Drugs Market Snippet by Region
2.2. Competitive Insights

3. General Anesthesia Drugs Key Market Trends

3.1. General Anesthesia Drugs Market Drivers
- 3.1.1. Impact Analysis of Market Drivers
3.2. General Anesthesia Drugs Market Restraints
- 3.2.1. Impact Analysis of Market Restraints
3.3. General Anesthesia Drugs Market Opportunities
3.4. General Anesthesia Drugs Market Future Trends

4. General Anesthesia Drugs Industry Study

4.1. PEST Analysis
4.2. Porter's Five Forces Analysis
4.3. Growth Prospect Mapping
4.4. Regulatory Framework Analysis

5. General Anesthesia Drugs Market: COVID-19 Impact Analysis

5.1. Pre-COVID-19 Impact Analysis
5.2. Post-COVID-19 Impact Analysis
- 5.2.1. Top Performing Segments
- 5.2.2. Marginal Growth Segments
- 5.2.3. Top Looser Segments
- 5.2.4. Marginal Loss Segments

6. General Anesthesia Drugs Market Landscape

6.1. General Anesthesia Drugs Market Share Analysis, 2023
6.2. Breakdown Data, by Key Manufacturer
- 6.2.1. Established Players' Analysis
- 6.2.2. Emerging Players' Analysis

7. General Anesthesia Drugs Market - By Type

7.1. Overview
- 7.1.1. Segment Share Analysis, By Type, 2023 & 2032 (%)
- 7.1.2. Propofol
- 7.1.3. Desflurane
- 7.1.4. Sevoflurane
- 7.1.5. Others

8. General Anesthesia Drugs Market - By Route Of Administration

8.1. Overview
- 8.1.1. Segment Share Analysis, By Route Of Administration, 2023 & 2032 (%)
- 8.1.2. Inhalation
- 8.1.3. Intravenous

9. General Anesthesia Drugs Market - By Surgery Type

9.1. Overview
- 9.1.1. Segment Share Analysis, By Surgery Type, 2023 & 2032 (%)
- 9.1.2. Knee and hip replacements
- 9.1.3. Cancer surgery
- 9.1.4. Heart surgeries
- 9.1.5. General surgery

10. General Anesthesia Drugs Market - By End-user

10.1. Overview
- 10.1.1. Segment Share Analysis, By End-user, 2023 & 2032 (%)
- 10.1.2. Ambulatory surgical centers
- 10.1.3. Hospital

11. General Anesthesia Drugs Market- By Geography

11.1. Introduction
- 11.1.1. Segment Share Analysis, By Geography, 2023 & 2032 (%)
11.2. North America
- 11.2.1. Overview
- 11.2.2. General Anesthesia Drugs Key Manufacturers in North America
- 11.2.3. North America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
- 11.2.4. North America Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
- 11.2.5. North America Market Size and Forecast, By Route Of Administration, 2019 - 2032 (US$ Million)
- 11.2.6. North America Market Size and Forecast, By Surgery Type, 2019 - 2032 (US$ Million)
- 11.2.7. North America Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
- 11.2.8. U.S.
  - 11.2.8.1. Overview
  - 11.2.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 11.2.8.3. U.S. Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
  - 11.2.8.4. U.S. Market Size and Forecast, By Route Of Administration, 2019 - 2032 (US$ Million)
  - 11.2.8.5. U.S. Market Size and Forecast, By Surgery Type, 2019 - 2032 (US$ Million)
  - 11.2.8.6. U.S. Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
- 11.2.9. Canada
  - 11.2.9.1. Overview
  - 11.2.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 11.2.9.3. Canada Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
  - 11.2.9.4. Canada Market Size and Forecast, By Route Of Administration, 2019 - 2032 (US$ Million)
  - 11.2.9.5. Canada Market Size and Forecast, By Surgery Type, 2019 - 2032 (US$ Million)
  - 11.2.9.6. Canada Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
11.3. Europe
- 11.3.1. Overview
- 11.3.2. General Anesthesia Drugs Key Manufacturers in Europe
- 11.3.3. Europe Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
- 11.3.4. Europe Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
- 11.3.5. Europe Market Size and Forecast, By Route Of Administration, 2019 - 2032 (US$ Million)
- 11.3.6. Europe Market Size and Forecast, By Surgery Type, 2019 - 2032 (US$ Million)
- 11.3.7. Europe Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
- 11.3.8. Germany
  - 11.3.8.1. Overview
  - 11.3.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 11.3.8.3. Germany Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
  - 11.3.8.4. Germany Market Size and Forecast, By Route Of Administration, 2019 - 2032 (US$ Million)
  - 11.3.8.5. Germany Market Size and Forecast, By Surgery Type, 2019 - 2032 (US$ Million)
  - 11.3.8.6. Germany Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
- 11.3.9. Italy
  - 11.3.9.1. Overview
  - 11.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 11.3.9.3. Italy Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
  - 11.3.9.4. Italy Market Size and Forecast, By Route Of Administration, 2019 - 2032 (US$ Million)
  - 11.3.9.5. Italy Market Size and Forecast, By Surgery Type, 2019 - 2032 (US$ Million)
  - 11.3.9.6. Italy Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
- 11.3.10. United Kingdom
  - 11.3.10.1. Overview
  - 11.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 11.3.10.3. United Kingdom Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
  - 11.3.10.4. United Kingdom Market Size and Forecast, By Route Of Administration, 2019 - 2032 (US$ Million)
  - 11.3.10.5. United Kingdom Market Size and Forecast, By Surgery Type, 2019 - 2032 (US$ Million)
  - 11.3.10.6. United Kingdom Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
- 11.3.11. France
  - 11.3.11.1. Overview
  - 11.3.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 11.3.11.3. France Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
  - 11.3.11.4. France Market Size and Forecast, By Route Of Administration, 2019 - 2032 (US$ Million)
  - 11.3.11.5. France Market Size and Forecast, By Surgery Type, 2019 - 2032 (US$ Million)
  - 11.3.11.6. France Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
- 11.3.12. Russia
  - 11.3.12.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 11.3.12.2. Russia Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
  - 11.3.12.3. Russia Market Size and Forecast, By Route Of Administration, 2019 - 2032 (US$ Million)
  - 11.3.12.4. Russia Market Size and Forecast, By Surgery Type, 2019 - 2032 (US$ Million)
  - 11.3.12.5. Russia Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
- 11.3.13. Netherlands
  - 11.3.13.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 11.3.13.2. Netherlands Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
  - 11.3.13.3. Netherlands Market Size and Forecast, By Route Of Administration, 2019 - 2032 (US$ Million)
  - 11.3.13.4. Netherlands Market Size and Forecast, By Surgery Type, 2019 - 2032 (US$ Million)
  - 11.3.13.5. Netherlands Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
- 11.3.14. Sweden
  - 11.3.14.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 11.3.14.2. Sweden Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
  - 11.3.14.3. Sweden Market Size and Forecast, By Route Of Administration, 2019 - 2032 (US$ Million)
  - 11.3.14.4. Sweden Market Size and Forecast, By Surgery Type, 2019 - 2032 (US$ Million)
  - 11.3.14.5. Sweden Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
- 11.3.15. Poland
  - 11.3.15.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 11.3.15.2. Poland Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
  - 11.3.15.3. Poland Market Size and Forecast, By Route Of Administration, 2019 - 2032 (US$ Million)
  - 11.3.15.4. Poland Market Size and Forecast, By Surgery Type, 2019 - 2032 (US$ Million)
  - 11.3.15.5. Poland Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
- 11.3.16. Rest of Europe
  - 11.3.16.1. Overview
  - 11.3.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 11.3.16.3. Rest of the Europe Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
  - 11.3.16.4. Rest of the Europe Market Size and Forecast, By Route Of Administration, 2019 - 2032 (US$ Million)
  - 11.3.16.5. Rest of the Europe Market Size and Forecast, By Surgery Type, 2019 - 2032 (US$ Million)
  - 11.3.16.6. Rest of the Europe Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
11.4. Asia Pacific (APAC)
- 11.4.1. Overview
- 11.4.2. General Anesthesia Drugs Key Manufacturers in Asia Pacific
- 11.4.3. Asia Pacific Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
- 11.4.4. Asia Pacific Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
- 11.4.5. Asia Pacific Market Size and Forecast, By Route Of Administration, 2019 - 2032 (US$ Million)
- 11.4.6. Asia Pacific Market Size and Forecast, By Surgery Type, 2019 - 2032 (US$ Million)
- 11.4.7. Asia Pacific Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
- 11.4.8. India
  - 11.4.8.1. Overview
  - 11.4.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 11.4.8.3. India Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
  - 11.4.8.4. India Market Size and Forecast, By Route Of Administration, 2019 - 2032 (US$ Million)
  - 11.4.8.5. India Market Size and Forecast, By Surgery Type, 2019 - 2032 (US$ Million)
  - 11.4.8.6. India Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
- 11.4.9. China
  - 11.4.9.1. Overview
  - 11.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 11.4.9.3. China Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
  - 11.4.9.4. China Market Size and Forecast, By Route Of Administration, 2019 - 2032 (US$ Million)
  - 11.4.9.5. China Market Size and Forecast, By Surgery Type, 2019 - 2032 (US$ Million)
  - 11.4.9.6. China Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
- 11.4.10. Japan
  - 11.4.10.1. Overview
  - 11.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 11.4.10.3. Japan Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
  - 11.4.10.4. Japan Market Size and Forecast, By Route Of Administration, 2019 - 2032 (US$ Million)
  - 11.4.10.5. Japan Market Size and Forecast, By Surgery Type, 2019 - 2032 (US$ Million)
  - 11.4.10.6. Japan Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
- 11.4.11. South Korea
  - 11.4.11.1. Overview
  - 11.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 11.4.11.3. South Korea Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
  - 11.4.11.4. South Korea Market Size and Forecast, By Route Of Administration, 2019 - 2032 (US$ Million)
  - 11.4.11.5. South Korea Market Size and Forecast, By Surgery Type, 2019 - 2032 (US$ Million)
  - 11.4.11.6. South Korea Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
- 11.4.12. Australia
  - 11.4.12.1. Overview
  - 11.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 11.4.12.3. Australia Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
  - 11.4.12.4. Australia Market Size and Forecast, By Route Of Administration, 2019 - 2032 (US$ Million)
  - 11.4.12.5. Australia Market Size and Forecast, By Surgery Type, 2019 - 2032 (US$ Million)
  - 11.4.12.6. Australia Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
- 11.4.13. Thailand
  - 11.4.13.1. Overview
  - 11.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 11.4.13.3. Thailand Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
  - 11.4.13.4. Thailand Market Size and Forecast, By Route Of Administration, 2019 - 2032 (US$ Million)
  - 11.4.13.5. Thailand Market Size and Forecast, By Surgery Type, 2019 - 2032 (US$ Million)
  - 11.4.13.6. Thailand Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
- 11.4.14. Indonesia
  - 11.4.14.1. Overview
  - 11.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 11.4.14.3. Indonesia Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
  - 11.4.14.4. Indonesia Market Size and Forecast, By Route Of Administration, 2019 - 2032 (US$ Million)
  - 11.4.14.5. Indonesia Market Size and Forecast, By Surgery Type, 2019 - 2032 (US$ Million)
  - 11.4.14.6. Indonesia Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
- 11.4.15. Philippines
  - 11.4.15.1. Overview
  - 11.4.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 11.4.15.3. Philippines Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
  - 11.4.15.4. Philippines Market Size and Forecast, By Route Of Administration, 2019 - 2032 (US$ Million)
  - 11.4.15.5. Philippines Market Size and Forecast, By Surgery Type, 2019 - 2032 (US$ Million)
  - 11.4.15.6. Philippines Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
- 11.4.16. Rest of APAC
  - 11.4.16.1. Overview
  - 11.4.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 11.4.16.3. Rest of APAC Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
  - 11.4.16.4. Rest of APAC Market Size and Forecast, By Route Of Administration, 2019 - 2032 (US$ Million)
  - 11.4.16.5. Rest of APAC Market Size and Forecast, By Surgery Type, 2019 - 2032 (US$ Million)
  - 11.4.16.6. Rest of APAC Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
11.5. Latin America
- 11.5.1. Overview
- 11.5.2. General Anesthesia Drugs Key Manufacturers in Latin America
- 11.5.3. Latin America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
- 11.5.4. Latin America Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
- 11.5.5. Latin America Market Size and Forecast, By Route Of Administration, 2019 - 2032 (US$ Million)
- 11.5.6. Latin America Market Size and Forecast, By Surgery Type, 2019 - 2032 (US$ Million)
- 11.5.7. Latin America Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
- 11.5.8. Brazil
  - 11.5.8.1. Overview
  - 11.5.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 11.5.8.3. Brazil Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
  - 11.5.8.4. Brazil Market Size and Forecast, By Route Of Administration, 2019 - 2032 (US$ Million)
  - 11.5.8.5. Brazil Market Size and Forecast, By Surgery Type, 2019 - 2032 (US$ Million)
  - 11.5.8.6. Brazil Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
- 11.5.9. Mexico
  - 11.5.9.1. Overview
  - 11.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 11.5.9.3. Mexico Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
  - 11.5.9.4. Mexico Market Size and Forecast, By Route Of Administration, 2019 - 2032 (US$ Million)
  - 11.5.9.5. Mexico Market Size and Forecast, By Surgery Type, 2019 - 2032 (US$ Million)
  - 11.5.9.6. Mexico Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
- 11.5.10. Argentina
  - 11.5.10.1. Overview
  - 11.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 11.5.10.3. Argentina Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
  - 11.5.10.4. Argentina Market Size and Forecast, By Route Of Administration, 2019 - 2032 (US$ Million)
  - 11.5.10.5. Argentina Market Size and Forecast, By Surgery Type, 2019 - 2032 (US$ Million)
  - 11.5.10.6. Argentina Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
- 11.5.11. Colombia
  - 11.5.11.1. Overview
  - 11.5.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 11.5.11.3. Colombia Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
  - 11.5.11.4. Colombia Market Size and Forecast, By Route Of Administration, 2019 - 2032 (US$ Million)
  - 11.5.11.5. Colombia Market Size and Forecast, By Surgery Type, 2019 - 2032 (US$ Million)
  - 11.5.11.6. Colombia Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
- 11.5.12. Rest of LATAM
  - 11.5.12.1. Overview
  - 11.5.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 11.5.12.3. Rest of LATAM Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
  - 11.5.12.4. Rest of LATAM Market Size and Forecast, By Route Of Administration, 2019 - 2032 (US$ Million)
  - 11.5.12.5. Rest of LATAM Market Size and Forecast, By Surgery Type, 2019 - 2032 (US$ Million)
  - 11.5.12.6. Rest of LATAM Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
11.6. Middle East and Africa
- 11.6.1. Overview
- 11.6.2. General Anesthesia Drugs Key Manufacturers in Middle East and Africa
- 11.6.3. Middle East and Africa Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
- 11.6.4. Middle East and Africa Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
- 11.6.5. Middle East and Africa Market Size and Forecast, By Route Of Administration, 2019 - 2032 (US$ Million)
- 11.6.6. Middle East and Africa Market Size and Forecast, By Surgery Type, 2019 - 2032 (US$ Million)
- 11.6.7. Middle East and Africa Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
- 11.6.8. Saudi Arabia
  - 11.6.8.1. Overview
  - 11.6.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 11.6.8.3. Saudi Arabia Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
  - 11.6.8.4. Saudi Arabia Market Size and Forecast, By Route Of Administration, 2019 - 2032 (US$ Million)
  - 11.6.8.5. Saudi Arabia Market Size and Forecast, By Surgery Type, 2019 - 2032 (US$ Million)
  - 11.6.8.6. Saudi Arabia Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
- 11.6.9. United Arab Emirates
  - 11.6.9.1. Overview
  - 11.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 11.6.9.3. United Arab Emirates Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
  - 11.6.9.4. United Arab Emirates Market Size and Forecast, By Route Of Administration, 2019 - 2032 (US$ Million)
  - 11.6.9.5. United Arab Emirates Market Size and Forecast, By Surgery Type, 2019 - 2032 (US$ Million)
  - 11.6.9.6. United Arab Emirates Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
- 11.6.10. Israel
  - 11.6.10.1. Overview
  - 11.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 11.6.10.3. Israel Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
  - 11.6.10.4. Israel Market Size and Forecast, By Route Of Administration, 2019 - 2032 (US$ Million)
  - 11.6.10.5. Israel Market Size and Forecast, By Surgery Type, 2019 - 2032 (US$ Million)
  - 11.6.10.6. Israel Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
- 11.6.11. Turkey
  - 11.6.11.1. Overview
  - 11.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 11.6.11.3. Turkey Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
  - 11.6.11.4. Turkey Market Size and Forecast, By Route Of Administration, 2019 - 2032 (US$ Million)
  - 11.6.11.5. Turkey Market Size and Forecast, By Surgery Type, 2019 - 2032 (US$ Million)
  - 11.6.11.6. Turkey Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
- 11.6.12. Algeria
  - 11.6.12.1. Overview
  - 11.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 11.6.12.3. Algeria Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
  - 11.6.12.4. Algeria Market Size and Forecast, By Route Of Administration, 2019 - 2032 (US$ Million)
  - 11.6.12.5. Algeria Market Size and Forecast, By Surgery Type, 2019 - 2032 (US$ Million)
  - 11.6.12.6. Algeria Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
- 11.6.13. Egypt
  - 11.6.13.1. Overview
  - 11.6.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 11.6.13.3. Egypt Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
  - 11.6.13.4. Egypt Market Size and Forecast, By Route Of Administration, 2019 - 2032 (US$ Million)
  - 11.6.13.5. Egypt Market Size and Forecast, By Surgery Type, 2019 - 2032 (US$ Million)
  - 11.6.13.6. Egypt Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
- 11.6.14. Rest of MEA
  - 11.6.14.1. Overview
  - 11.6.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 11.6.14.3. Rest of MEA Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
  - 11.6.14.4. Rest of MEA Market Size and Forecast, By Route Of Administration, 2019 - 2032 (US$ Million)
  - 11.6.14.5. Rest of MEA Market Size and Forecast, By Surgery Type, 2019 - 2032 (US$ Million)
  - 11.6.14.6. Rest of MEA Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)

12. Key Vendor Analysis- General Anesthesia Drugs Industry

12.1. Competitive Dashboard
12.2. Company Profiles
- 12.2.1. Pfizer Inc.
- 12.2.2. Paion AG
- 12.2.3. B. Braun Melsungen
- 12.2.4. Avet Pharmaceuticals Inc
- 12.2.5. Baxter International Inc.
- 12.2.6. Abbott Laboratories
- 12.2.7. Fresenius SE and Co. KGaA
- 12.2.8. Abbvie Inc,
- 12.2.9. AstraZeneca plc
- 12.2.10. Hikma Pharmaceuticals plc
- 12.2.11. Others

13. 360 Degree Analyst View

14. Appendix

14.1. Research Methodology
14.2. References
14.3. Abbreviations
14.4. Disclaimer
14.5. Contact Us